celecoxib has been researched along with paraquat in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Buechner, S; Dassati, S; Schweigreiter, R; Waldner, A | 1 |
| Singh, C; Yadav, A | 1 |
3 other study(ies) available for celecoxib and paraquat
| Article | Year |
|---|---|
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Celecoxib promotes survival and upregulates the expression of neuroprotective marker genes in two different in vitro models of Parkinson's disease.
Topics: Apolipoproteins D; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Celecoxib; Cell Line, Tumor; Hippocampus; Humans; Neuroprotection; Oxidopamine; Paraquat; Parkinson Disease, Secondary; Up-Regulation | 2021 |
Cyclooxygenase-2 activates the free radical-mediated apoptosis of polymorphonuclear leukocytes in the maneb- and paraquat-intoxicated rats.
Topics: Adenosine Diphosphate; Animals; Apoptosis; Caspase 3; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytochromes c; Free Radicals; Humans; JNK Mitogen-Activated Protein Kinases; Lipid Peroxides; Maneb; Neutrophils; NF-kappa B; Oxidative Stress; Paraquat; Pesticides; Rats; Ribose; Superoxide Dismutase | 2022 |